131 related articles for article (PubMed ID: 7021362)
1. Immunobiology of minor histocompatibility antigens in the lethal graft-versus-host-reaction induced in adult mice.
Halle-Pannenko O; Pritchard LL; Mathé G
Haematol Blood Transfus; 1980; 25():75-91. PubMed ID: 7021362
[No Abstract] [Full Text] [Related]
2. Non-H-2 antigens can induce high GVH mortality in adult recipients of normal cells.
Halle-Pannenko O; Pritchard LL; Motta R; Mathé G
Biomedicine; 1978 Nov; 29(7):253-5. PubMed ID: 34444
[TBL] [Abstract][Full Text] [Related]
3. Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers.
Korngold R; Sprent J
J Exp Med; 1982 Mar; 155(3):872-83. PubMed ID: 6977610
[TBL] [Abstract][Full Text] [Related]
4. Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex.
Korngold R; Sprent J
Immunol Rev; 1983; 71():5-29. PubMed ID: 6221991
[TBL] [Abstract][Full Text] [Related]
5. Maternal alloimmune reactions towards the murine conceptus and graft-versus-host reaction (GVHR). I. Priming for anti-paternal GVHR by gestation.
Voisin JE; Monnot P; Voisin GA
J Reprod Immunol; 1986 Jul; 9(2):73-83. PubMed ID: 3746777
[TBL] [Abstract][Full Text] [Related]
6. Regulation of delayed type hypersensitivity to host histocompatibility antigens during graft-versus-host reactions.
Benner R; Wolters EA; Bril H; Molendijk A; van Oudenaren A
Immunol Rev; 1985 Dec; 88():25-57. PubMed ID: 2935486
[TBL] [Abstract][Full Text] [Related]
7. H-2 restriction of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers in mice.
Korngold R; Sprent J
Transplant Proc; 1981 Mar; 13(1 Pt 2):1217-9. PubMed ID: 7022928
[No Abstract] [Full Text] [Related]
8. Maternal modification of antigen recognition in the ova-transfer substrain R3eB.
Uphoff DE
J Natl Cancer Inst; 1972 Feb; 48(2):517-22. PubMed ID: 4405705
[No Abstract] [Full Text] [Related]
9. Lethal graft-versus-host reaction to minor histocompatibility antigens is decreased by donor immunization against H-2 and varies as a function of the H-2 haplotype.
Halle-Pannenko O; Pritchard LL; Motta R; Mathe G
Transplant Proc; 1979 Mar; 11(1):652-6. PubMed ID: 36701
[No Abstract] [Full Text] [Related]
10. Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens: role of Mlsa and K/I region antigens in the induction of unresponsiveness by alloimmunization.
Halle-Pannenko O; Pritchard LL; Festenstein H; Berumen L
J Immunogenet; 1986; 13(5-6):437-50. PubMed ID: 3305712
[TBL] [Abstract][Full Text] [Related]
11. Both class I and class II responsive T cell subsets can separately initiate lethal graft-versus-host disease in H-2-incompatible murine radiation chimeras.
Carmody L; Atkinson K; Cooley M; Chapman G; Biggs J; McKenzie I
Transplant Proc; 1987 Apr; 19(2):2876-8. PubMed ID: 3105125
[No Abstract] [Full Text] [Related]
12. Biology and genetics of hybrid resistance.
Bennett M
Adv Immunol; 1987; 41():333-445. PubMed ID: 2891262
[No Abstract] [Full Text] [Related]
13. Tolerance to minor histocompatibility antigens.
Rayfield LS; Brent L; Samuel K
Immunol Lett; 1988 Mar; 17(3):253-9. PubMed ID: 3286488
[TBL] [Abstract][Full Text] [Related]
14. Protection against graft-versus-host disease by large doses of donor CD4+ T cells: a novel approach to bone marrow transplantation.
Heath WR; Miller JF; Sprent J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1222-4. PubMed ID: 8442095
[No Abstract] [Full Text] [Related]
15. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.
Hamilton BL; Bevan MJ; Parkman R
J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246
[TBL] [Abstract][Full Text] [Related]
16. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.
Annat J; Churaqui E; Dutartre P; Bruley-Rosset M
Transplantation; 1996 Sep; 62(6):721-9. PubMed ID: 8824467
[TBL] [Abstract][Full Text] [Related]
17. Parameters involved in the induction and abrogation of the lethal graft-versus-host reaction directed against non-H-2 antigens.
Halle-Pannenko O; Pritchard LL; Bruley-Rosset M; Berumen L; Motta R
Immunol Rev; 1985 Dec; 88():59-85. PubMed ID: 2417936
[TBL] [Abstract][Full Text] [Related]
18. Differential responsiveness to H-2-subregion-coded antigens in graft versus host and host versus graft reactions.
Wolters EA; van der Kwast TH; Odijk LM; Benner R
Cell Immunol; 1981 Jan; 57(2):389-99. PubMed ID: 6971165
[No Abstract] [Full Text] [Related]
19. Graft-versus-host disease: immunobiological aspects.
Tutschka PJ
Haematol Blood Transfus; 1983; 28():97-101. PubMed ID: 6345301
[No Abstract] [Full Text] [Related]
20. Soluble H-2 antigens: effect on graft-versus-host reaction and factors influencing its effect on host-versus-skin-graft reaction.
Halle-Pannenko O; Martyre MC; Mathé G
Transplant Proc; 1972 Dec; 4(4):517-21. PubMed ID: 4405145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
